Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00436007
Status:
COMPLETED
Last Update Posted:
2018-08-16
First Post:
2007-02-15
Brief Title:
Safety and Immunogenicity Study of GSK Biologicals Malaria Vaccine 257049 When Incorporated Into an EPI Regimen
Sponsor:
Organization:
GlaxoSmithKline